Total synthesis of mycolactones A and B

Tetrahedron

Volumn 63, Issue 26, 2007, Pages 5739-5753

  Song, Fengbin ^a   Fidanze, Steve ^a   Benowitz, Andrew B ^a   Kishi, Yoshito ^a  

^a HARVARD UNIVERSITY   (United States)

Author keywords

Buruli ulcer; Mycolactones; Total synthesis

Indexed keywords

LACTONE DERIVATIVE; MACROLIDE; MYCOLACTONE A; MYCOLACTONE B; UNCLASSIFIED DRUG;

ARTICLE; DRUG SYNTHESIS; PRIORITY JOURNAL; STEREOCHEMISTRY;

EID: 34248631378     PISSN: 00404020     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tet.2007.02.057     Document Type: Article

References (55)

1. For a general review on Buruli ulcer, see:
2. In: Asiedu K., Scherpbier R., and Ravinglione M. (Eds). Buruli Ulcer: Mycobacterium ulcerans Infection (2000), World Health Organization, Geneva, Switzerland
3. Rohr J. Angew. Chem., Int. Ed. 39 (2000) 2847
4. Marsollier L., Robert R., Aubry J., Saint Andre J.-P., Kouakou H., Legras P., Manceau A.-L., Mahaza C., and Carbonnelle B. Appl. Environ. Microbiol. 68 (2002) 4623
5. George K.M., Chatterjee D., Gunawardana G., Welty D., Hayman J., Lee R., and Small P.L.C. Science 283 (1999) 854
6. Gunawardana G., Chatterjee D., George K.M., Brennan P., Whittern D., and Small P.L.C. J. Am. Chem. Soc. 121 (1999) 6092
7. Benowitz A.B., Fidanze S., Small P.L.C., and Kishi Y. J. Am. Chem. Soc. 123 (2001) 5128
8. Kobayashi Y., Hayashi N., Tan C.-H., and Kishi Y. Org. Lett. 3 (2001) 2245
9. Hayashi N., Kobayashi Y., and Kishi Y. Org. Lett. 3 (2001) 2249
10. Kobayashi Y., Hayashi N., and Kishi Y. Org. Lett. 3 (2001) 2253
11. Fidanze S., Song F., Szlosek-Pinaud M., Small P.L.C., and Kishi Y. J. Am. Chem. Soc. 123 (2001) 10117
12. Song F., Fidanze S., Benowitz A.B., and Kishi Y. Org. Lett. 4 (2002) 647
13. Hong H., Gates P.J., Staunton J., Stinear T., Cole S.T., Leadlay P.F., and Spencer J.B. Chem. Commun. (2003) 2822
14. Mve-Obiang A., Lee R.E., Portaels F., and Small P.L.C. Infect. Immun. 71 (2003) 774
15. See Ref. 9b.
16. Hong H., Spencer J.B., Porter J.L., Leadlay P.F., and Stinear T. ChemBioChem 6 (2005) 643
17. Hong H., Stinear T., Skelton P., Spencer J.B., and Leadlay P.F. Chem. Commun. (2005) 4306
18. Mve-Obiang A., Lee R.E., Umstot E.S., Trott K.A., Grammer T.C., Parker J.M., Ranger B.S., Grainger R., Mahrous E.A., and Small P.L.C. Infect. Immun. 73 (2005) 3307
19. Ranger B.S., Mahrous E.A., Mosi L., Adusumilli S., Lee R.E., Colorni A., Phodes M., and Small P.L.C. Infect. Immun. 74 (2006) 6037
20. Gurjar M.K., and Cherian J. Heterocycles 55 (2001) 1095
21. Tong Z., Ma S., and Fuchs P.L. J. Sulfur Chem. 25 (2004) 1
22. van Summeren R.P., Feringa B.L., and Minnaard A.J. Org. Biomol. Chem. 3 (2005) 2524
23. Yin N., Wang G., Qian M., and Negishi E. Angew. Chem., Int. Ed. 45 (2006) 2916
24. Alexander M.D., Fontaine S.D., La Clair J.J., DiPasquale A.G., Rheingold A.L., and Burkart M.D. Chem. Commun. (2006) 4602
25. A preliminary report of this work has been reported in Ref. 8.
26. Paterson I., and Craw P.A. Tetrahedron Lett. 30 (1989) 5799
27. Jacobsen E.N., Markó I., Mungall W.S., Schröder G., and Sharpless K.B. J. Am. Chem. Soc. 110 (1988) 1968
28. Sharpless K.B., Amberg W., Bennani Y.L., Crispino G.A., Hartung J., Jeong K.-S., Kwong H.-L., Morikawa K., Wang Z.-M., Xu D., and Zhang X.-L. J. Org. Chem. 57 (1992) 2768
29. Asymmetric dihydroxylation under the stoichiometric conditions gave a much higher selectivity. For example, a >20:1 ratio was obtained in the presence of the Corey diamine ligand:. Corey E.J., Jardine P.D., Virgil S., Yuen P.-W., and Connel R.D. J. Am. Chem. Soc. 111 (1989) 9243
30. 1H NMR spectrum of crude product.
31. Inanaga J., Hirata K., Saeki H., Katsuki T., and Yamaguchi M. Bull. Chem. Soc. Jpn. 52 (1979) 1989
32. Hikota M., Sakurai Y., Horita K., and Yonemitsu O. Tetrahedron Lett. 31 (1990) 6367
33. Remote diastereomers are referred to as the diastereomers due to the stereocenter(s) present outside a self-contained box(es); see:
34. Kobayashi K., Tan C.-H., and Kishi Y. Helv. Chim. Acta 83 (2000) 2562
35. Boyle C.D., Harmange J.-C., and Kishi Y. J. Am. Chem. Soc. 116 (1994) 4995
36. Mycolactones are known to exhibit intriguing biological properties; see:
37. George K.M., Pascopella L., Welty D.M., and Small P.L.C. Infect. Immun. 68 (2000) 877
38. Dobos K.M., Small P.L., Deslauriers M., Quinn F.D., and King C.H. Infect. Immun. 69 (2001) 7182 and references cited therein. We thank Professor P.L.C. Small at the University of Tennessee for performing biological tests
39. Brown H.C., and Bhat K.S. J. Am. Chem. Soc. 108 (1986) 5919
40. Brown H.C., Bhat K.S., and Randad R.S. J. Org. Chem. 54 (1989) 1570
41. Seyferth D., Marmor R.S., and Hilbert P. J. Org. Chem. 36 (1971) 1379
42. Gilbert J.C., and Weerasooriya U. J. Org. Chem. 47 (1982) 1837
43. Brown D.G., Velthuisen E.J., Commerford J.R., Brisbois R.G., and Hoye T.R. J. Org. Chem. 61 (1996) 2540
44. Hart D.W., and Schwartz J. J. Am. Chem. Soc. 96 (1974) 8115
45. Schwartz J., and Labinger J.A. Angew. Chem., Int. Ed. Engl. 15 (1976) 333
46. With use of the C1-carboxylate aldehyde (shown below) for Brown crotylboration, the two steps required for the oxidation of the primary alcohol to the acid could be eliminated. However, the crotylboration gave a 3:1 mixture of the desired product and the δ-lactone.{A figure is presented}
47. Seebach D., and Wasmuth D. Helv. Chim. Acta 63 (1980) 197
48. Guindon Y., Yoakim C., Gorys V., Ogilvie W.W., Delorme D., Renaud J., Robinson G., Lavallée J.-F., Slassi A., Jung G., Rancourt J., Durkin K., and Liotta D. J. Org. Chem. 59 (1994) 1166
49. Leigh D.A., Martin R.P., Smart J.P., and Truscello A.M. J. Chem. Soc., Chem. Commun. (1994) 1373
50. Yamaguchi M., and Hirao I. Tetrahedron Lett. 24 (1983) 391
51. Negishi E., Valente L.F., and Kobayashi M. J. Am. Chem. Soc. 102 (1980) 3298
52. Legoff E. J. Org. Chem. 29 (1964) 2048
53. There are several modified protocols known for the Negishi coupling reaction. The procedure used here was modified from the Stille coupling protocol reported by Corey:. Han X., Stoltz B.M., and Corey E.J. J. Am. Chem. Soc. 121 (1999) 7600
54. To adopt this synthesis for our purpose, it would be necessary to adjust the C12′-OH protecting group, i.e., from the MOM ether to the TBS ether.
55. Judd T.C., Bischoff A., Kishi Y., Adusumilli S., and Small P.L.C. Org. Lett. 6 (2004) 4901